BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 74.14 USD 0.16% Market Closed
Market Cap: 14.3B USD

Wall Street
Price Targets

BBIO Price Targets Summary
BridgeBio Pharma Inc

Wall Street analysts forecast BBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBIO is 85.26 USD with a low forecast of 42.63 USD and a high forecast of 115.5 USD.

Lowest
Price Target
42.63 USD
42% Downside
Average
Price Target
85.26 USD
15% Upside
Highest
Price Target
115.5 USD
56% Upside
BridgeBio Pharma Inc Competitors:
Price Targets
NRIX
Nurix Therapeutics Inc
51% Upside
NVAX
Novavax Inc
93% Upside
002252
Shanghai RAAS Blood Products Co Ltd
11% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
INCY
Incyte Corp
6% Downside
GILD
Gilead Sciences Inc
8% Upside
CDNA
CareDx Inc
22% Upside
IONS
Ionis Pharmaceuticals Inc
8% Upside

Revenue
Forecast

Revenue Estimate
BridgeBio Pharma Inc

The compound annual growth rate of BridgeBio Pharma Inc's revenue for the next 4 years is 79%.

N/A
Past Growth
79%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BridgeBio Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
BridgeBio Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-24%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BBIO's stock price target?
Price Target
85.26 USD

According to Wall Street analysts, the average 1-year price target for BBIO is 85.26 USD with a low forecast of 42.63 USD and a high forecast of 115.5 USD.

What is BridgeBio Pharma Inc's Revenue forecast?
Projected CAGR
79%

The compound annual growth rate of BridgeBio Pharma Inc's revenue for the next 4 years is 79%.

Back to Top